Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangqi Shengji Powder is a traditional Chinese medicine (TCM) topical formulation developed by The First Affiliated Hospital of Zhejiang University of Chinese Medicine for the treatment of chronic refractory diabetic ulcers. The primary active component is *Astragalus membranaceus* (Huangqi), which is traditionally used to tonify Qi and promote tissue regeneration. The powder is applied topically to wound surfaces to stimulate granulation tissue formation, improve local microcirculation, and accelerate the healing process of long-standing ulcers that are resistant to conventional treatments. It works by modulating inflammatory cytokines and promoting the expression of growth factors such as VEGF and TGF-beta.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huangqi shengji powder.